Research
Hormonal
Bariatric surgery patients often have higher baseline HbA1c and require more insulin, yet still achieve higher remission rates than usual care patients.
Even if your diabetes is severe (high HbA1c) or you require insulin, bariatric surgery may still offer a chance for remission, potentially more so than lifestyle changes alone. Do not rule out surgery solely based on the severity of your diabetes or current medication use.
GoodQualifiesHIGH confidence
bariatric surgery patients were younger, had higher HbA1c, odd ratio, 3.71 to 2.54, and 0.25, 95 CI, 0.02–0.48, respectively, insulin use was higher, and glucagon-like peptide agonists use was lower among bariatric surgery patients
Why this rating
Meta-analysis data, though heterogeneity exists.
Source
Metabolic surgery versus usual care effects on diabetes remission: a systematic review and meta-analysis
Hyder Osman Mirghani et al. · Diabetology & Metabolic Syndrome · 2023
DOI 10.1186/s13098-023-01001-4
Meta-analysis · 12 studiesCited 17×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →